ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Insights on Intrepid 2-Yr Mitral TF EFS"
Episode Synopsis
The Intrepid TMVR system just released 2-year transfemoral EFS outcomes at NY Valves. This discussion provides a deeper dive into what this data means for the Intrepid mitral program and perspectives on the transcatheter landscape.
More episodes of the podcast Talking Points
The CLEAR SYNERGY (OASIS 9) Trial
17/09/2025
The NOTION-3 Trial
03/09/2025
TMVR in the Heart Failure Paradigm
15/08/2025
The ABYSS Trial
13/08/2025
Patient Selection and Treatment Goals
11/08/2025
Women's Health Study: Biomarkers
06/08/2025
Echocardiography and Quality Data
04/08/2025
New ESC Guidelines for AF
23/07/2025
The STEEER-AF Trial
09/07/2025
The EPIC-CAD Trial
02/07/2025
In God we trust